Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway

被引：0
|
作者：
Jianyou Gu
Xiao Wang
Ling Zhang
Jingjing Xiang
Jingya Li
Zheng Chen
Yu Zhang
Junfa Chen
Jianping Shen
机构：
[1] Zhejiang Chinese Medical University,The First Affiliated Hospital
[2] Key Laboratory of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province,undefined
来源：
BMC Complementary Medicine and Therapies | / 21卷
关键词：
Matrine; DLBCL; C-Myc; CaMKIIγ; CDK6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] MYC Protein Expression Correlates with C-MYC Transcriptional Activity in Absence of Gene Rearrangement in Diffuse Large B-Cell Lymphoma
    Misyurina, Anna
    Misyurin, Vsevolod Andreevich
    Misyurin, Andrey Vitalievich
    Kravchenko, Sergey Kirillovich
    Kovrigina, Alla M.
    Baryakh, Elena Alexandrovna
    Vorobiev, Vladimir Ivanovich
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [22] USP37 promotes diffuse large B-cell lymphoma progression by deubiquitinating and stabilizing c-myc
    Li, Ying
    Wang, Wei
    Sun, Lingjie
    Huang, Junxia
    Ma, Xiaolin
    Li, Saisai
    Shi, Xue
    JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (01)
  • [23] Clinical significance of 8q24/c-MYC translocation in diffuse large B-cell lymphoma
    Niitsu, Nozomi
    Okamoto, Masataka
    Miura, Ikuo
    Hirano, Masami
    CANCER SCIENCE, 2009, 100 (02) : 233 - 237
  • [24] CDK6 overexpression resulted from microRNA-320d downregulation promotes cell proliferation in diffuse large B-cell lymphoma
    Su, Hong
    Chang, Jiang
    Xu, Mengwei
    Sun, Ruifang
    Wang, Jinfen
    ONCOLOGY REPORTS, 2019, 42 (01) : 321 - 327
  • [25] Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways
    Hama, Yasuhiro
    Banjo, Toshihiro
    Honma, Daisuke
    Takata, Yoshimi
    Nosaka, Emi
    Shiroishi, Machiko
    Watanabe, Kenji
    Yamamoto, Yuka
    Hirata, Tsuyoshi
    Nakano, Rika
    Inaki, Koichiro
    Goto, Hiroki
    Totoki, Yusuke
    Kataoka, Miki
    Lim, Kyungtaek
    Wada, Chisa
    Kumazawa, Eiji
    Tsutsumi, Shinji
    BLOOD, 2019, 134
  • [26] CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma
    Fujisawa, S
    Tanioka, F
    Matsuoka, T
    Ozawa, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (04) : 315 - 318
  • [27] CD5+ Diffuse Large B-Cell Lymphoma with c-myc/IgH Rearrangement Presenting as Primary Effusion Lymphoma
    Shinya Fujisawa
    Fumihiko Tanioka
    Toshihiko Matsuoka
    Takachika Ozawa
    International Journal of Hematology, 2005, 81 : 315 - 318
  • [28] MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
    Shao, Yuan
    Qu, Yiping
    Dang, Siwen
    Yao, Bowen
    Ji, Meiju
    CANCER CELL INTERNATIONAL, 2013, 13
  • [29] MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
    Yuan Shao
    Yiping Qu
    Siwen Dang
    Bowen Yao
    Meiju Ji
    Cancer Cell International, 13
  • [30] MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway
    Wang, Wei-Ge
    Jiang, Xiang-Nan
    Liu, Ze-Bing
    Zhou, Xiao-Yan
    Li, Xiao-Qiu
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (04) : 541 - 549
12345